Literature DB >> 31190323

Net survival of patients with colorectal cancer: a comparison of two periods.

Zdravko Štor1, Rok Blagus2, Alessandro Tropea3, Antonio Biondi4.   

Abstract

BACKGROUND: The purpose of our analysis was to compare the results of treatment in patients who underwent resection for colorectal carcinoma.
METHODS: In the period from 1/1/1991 to 31/12/2000 1478 patients with colorectal carcinoma underwent potentially curative resection. We divided them into two 5-year period groups according to different treatment regimes. The 5-year net survival rate was estimated, where the net survival is the probability of survival derived solely from the cancer-specific hazard.
RESULTS: In a 10-year period, we resected 1478 patients. The 5-year net survival rate for R0-resected patients with colon cancer increased from 76.3 to 85.2% between the periods 1991-1995 and 1995-2000. The 5-year net survival rate for R0-resected patients with rectal cancer also increased from 67.5 to 73% in the same period.
CONCLUSION: A comparison of the 5-year net survival rate for R0-resected patients with colorectal cancer increased in the last period from 1995 to 2000 compared with the period from 1991 to 1995. In multivariate analysis, early stage at diagnosis and adjuvant chemotherapy was both associated with better net survival after surgery with curative intent. The improvement of net survival is potentially the result of combination of better surgical and adjuvant therapy.

Entities:  

Keywords:  5-Year net survival rate; Colorectal cancer; Standard oncological treatment

Mesh:

Year:  2019        PMID: 31190323     DOI: 10.1007/s13304-019-00662-z

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  54 in total

Review 1.  Adjuvant therapy of rectal cancer.

Authors:  B D Minsky
Journal:  Semin Oncol       Date:  1999-10       Impact factor: 4.929

2.  Anterior resection with total mesorectal excision.

Authors:  R J Steele
Journal:  J R Coll Surg Edinb       Date:  1999-02

Review 3.  Mobilization of the rectum: anatomic concepts and the bookshelf revisited.

Authors:  Pierre Chapuis; Les Bokey; Marius Fahrer; Gael Sinclair; Nikolai Bogduk
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

4.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

5.  Improvement in colorectal cancer survival: a population-based study.

Authors:  Emmanuel Mitry; Anne-Marie Bouvier; Jacques Esteve; Jean Faivre
Journal:  Eur J Cancer       Date:  2005-09-01       Impact factor: 9.162

6.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

7.  Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.

Authors:  Eduard Vrdoljak; Gyorgy Bodoky; Jacek Jassem; Razvan A Popescu; Jozef Mardiak; Robert Pirker; Tanja Čufer; Semir Bešlija; Alexandru Eniu; Vladimir Todorović; Kateřina Kubáčková; Galia Kurteva; Zorica Tomašević; Agim Sallaku; Snezhana Smichkoska; Žarko Bajić; Branimir I Šikić
Journal:  Oncologist       Date:  2016-07-08

8.  Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials.

Authors: 
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

9.  Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres.

Authors:  A de Buck van Overstraeten; E J Eshuis; S Vermeire; G Van Assche; M Ferrante; G R D'Haens; C Y Ponsioen; A Belmans; C J Buskens; A M Wolthuis; W A Bemelman; A D'Hoore
Journal:  Br J Surg       Date:  2017-07-26       Impact factor: 6.939

Review 10.  Radiology of colorectal cancer.

Authors:  M E J Pijl; A S Chaoui; R L Wahl; J A van Oostayen
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.